NCT04524351: A trial that was reported late by Annovis Bio Inc.
This trial has reported, although it was 148 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04524351 |
|---|---|
| Title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Posiphen® in Subjects With Early Alzheimer's Disease (AD) or Early Parkinson's Disease (PD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 14, 2020 |
| Completion date | Aug. 16, 2021 |
| Required reporting date | Aug. 16, 2022, midnight |
| Actual reporting date | Jan. 11, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 148 |